Portland, OR, United States of America

Skylar J Ferrara

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Skylar J Ferrara: Innovator in Neuropharmaceuticals

Introduction

Skylar J Ferrara is a prominent inventor based in Portland, Oregon. She has made significant contributions to the field of neuropharmaceuticals, focusing on developing novel therapeutic agents for central nervous system disorders. With a total of 4 patents to her name, Ferrara is recognized for her innovative approaches to drug formulation.

Latest Patents

Ferrara's latest patents include groundbreaking work on amide prodrugs of small molecule nuclear receptor modulators. These novel amide prodrug forms of pharmaceutically active agents are designed to address various central nervous system disorders. Additionally, she has developed amide compounds and pharmaceutical compositions that are effective in treating neurodegenerative diseases. The methods she has disclosed involve administering these compounds or pharmaceutical compositions to subjects, showcasing her commitment to advancing medical science.

Career Highlights

Skylar J Ferrara is affiliated with Oregon Health & Science University, where she continues her research and development efforts. Her work has garnered attention for its potential impact on treating complex neurological conditions. Ferrara's dedication to her field is evident in her innovative research and the practical applications of her inventions.

Collaborations

Some of her notable coworkers include Thomas S Scanlan and James Matthew Meinig. Their collaborative efforts contribute to the advancement of research in neuropharmaceuticals and enhance the potential for developing effective treatments.

Conclusion

Skylar J Ferrara stands out as a leading inventor in the realm of neuropharmaceuticals. Her innovative patents and commitment to research are paving the way for new therapeutic options for patients with central nervous system disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…